Shots: Craig shared with our readers the preclinical study results of C101248 demonstrating its pharmacological activity and validation of the NETSseq platform as an effective method to interpret new therapeutic targets for Alzheimer’s disease He also elaborated on how the combination of the NETSseq platform and C101248 will help in the identification and development of…
Chitkara University and DeepSynergy presents the Pharma Tech Conclave 2023. The conference will be held on 3rd Mar 2023 from 9:00 am to 5:00 pm IST at the Chitkara College of Pharmacy, Chitkara University, Chandigarh. The global pharmaceutical industry is undergoing transformational changes due to advancements in technological innovations that aim to fundamentally alter how patients…
The dependability of digital technology has augmented through a variety of industries, including communication, transportation, manufacturing, medical, and pharmaceutical companies. Development in technologies has made it possible to merge medical science with digital platforms, allowing for the individualised delivery of services to a large population, making therapy more effective and convenient. Today, technology has become…
In an interview with PharmaShots, Dr. Bob Deans, Chief Scientific Officer at Synthego shares insights on the wide availability of its new CRISPR-based platform, Eclipse. Synthego created the Eclipse platform to enhance disease modeling, drug target identification, and validation, and accelerate cell therapy manufacturing.Shots:Eclipse uses MLto apply experience from several hundred thousand genome edits across…

